Fagron N.V.
A global pharmaceutical compounding company focused on personalized medicine.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Manufacturing
Description
Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-09-16 08:00 |
Disclosure of received notifications
|
English | 12.2 KB | ||
| 2019-09-16 08:00 |
Disclosure of received notifications
|
English | 12.2 KB | ||
| 2019-09-16 08:00 |
Disclosure of received notifications
|
English | 12.0 KB | ||
| 2019-09-16 07:00 |
WPEF structuur controleketen Fagron Sept 20190911 pdf_00910479.pdf
|
Russian | 35.0 KB | ||
| 2019-09-16 07:00 |
CGC.pdf
|
English | 124.4 KB | ||
| 2019-09-16 07:00 |
WPEF_Transparantiekennisgeving_Fagron_korte versie pdf_00910824.pdf
|
Dutch | 613.9 KB | ||
| 2019-09-16 07:00 |
Fagron Kennisgeving 150919 ENG DEF.pdf
|
English | 171.2 KB | ||
| 2019-09-16 07:00 |
Fagron Kennisgeving 150919 NED DEF.pdf
|
Dutch | 165.3 KB | ||
| 2019-08-05 09:07 |
Fagron NV: Turnover increase of 10.6%; REBITDA increased to €55.6 million
|
Dutch | 104.5 KB | ||
| 2019-08-05 09:07 |
Fagron NV: Turnover increase of 10.6%; REBITDA increased to €55.6 million
|
Dutch | 104.4 KB | ||
| 2019-08-05 07:00 |
Fagron H1-2019 Results DEF ENG.pdf
|
English | 408.8 KB | ||
| 2019-08-05 07:00 |
Fagron H1-2019 Results DEF NED.pdf
|
Dutch | 388.8 KB | ||
| 2019-08-05 07:00 |
IFS s1-2019 ENG incl. DTT.pdf
|
English | 552.5 KB | ||
| 2019-08-05 07:00 |
IFS S1-2019 NL incl. DTT.pdf
|
Dutch | 594.0 KB | ||
| 2019-07-17 08:40 |
Disclosure of received notification
|
Dutch | 32.8 KB |
Automate Your Workflow. Get a real-time feed of all Fagron N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fagron N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fagron N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |
Peer Companies
